CartiHeal Performs First Belgian Case in Agili-C Study
CartiHeal announced successful enrollment of the first Belgian patient in the Agili-C IDE pivotal study....
CartiHeal announced successful enrollment of the first Belgian patient in the Agili-C IDE pivotal study....
CartiHeal announced successful enrollment of the first two U.S. patients in the Agili-C IDE pivotal study....
BONESUPPORT received regulatory approval from Health Canada for CERAMENT® G gentamicin-eluting injectable ceramic bone graft substitute....
Cerapedics enrolled the first patients in an IDE clinical trial evaluating P-15L Bone Graft vs. autograft in TLIF....
Wright Medical commenced U.S. launch of the PROstep Minimally Invasive Surgery System and AUGMENT® Injectable Bone Graft....
Kuros Biosciences announced the first commercial uses of MagnetOs bone graft substitute in the U.S. and U.K....
Lipogems received FDA 510(k) clearance to market a Microfragmented Adipose Tissue Transplant system for use in orthopaedic and arthroscopic procedures. ...
In the Phase III 16-02 clinical trial of Anika Therapeutics' CINGAL, statistically significant results in pain reduction were not demonstrated...
Wright Medical received FDA premarket approval for AUGMENT® Injectable Bone Graft, serving as an alternative to autograft in hindfoot and ankle fusion....
Kuros Biosciences commenced a multicenter study comparing MagnetOs bone graft substitute vs. autologous bone in spinal fusion....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.